ClinConnect ClinConnect Logo
Search / Trial NCT01581580

Deep Brain Stimulation Surgery for Movement Disorders

Launched by NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE (NINDS) · Apr 19, 2012

Trial Information

Current as of June 26, 2025

Recruiting

Keywords

Parkinson's Disease Deep Brain Stimulation Neurophysiology Movement Disorder Dystonia Parkinson Disease Essential Tremor

ClinConnect Summary

This clinical trial is studying a surgery called Deep Brain Stimulation (DBS) for people with movement disorders such as Parkinson's disease, essential tremor, and dystonia. DBS is used when other treatments haven’t worked well. During the surgery, a small device is placed under the skin in the chest, which sends signals to specific areas of the brain to help control abnormal movements. Researchers want to understand how this surgery affects these conditions and also learn more about brain function while the procedure is happening.

To participate in this trial, you need to be at least 18 years old and have one of the specified movement disorders that aren't well controlled by medications. If you join, you'll go through some tests before the surgery to ensure it's safe for you. During the surgery, you'll perform some movement and memory exercises to help doctors see how well the stimulation is working. After the surgery, you'll stay in the hospital for recovery and have follow-up visits to adjust the device and check your progress in movement and overall quality of life. This is an important opportunity to gain more insight into how DBS can help manage movement disorders.

Gender

ALL

Eligibility criteria

  • * INCLUSION CRITERIA:
  • To be eligible for entry into the study, candidates must meet all the following criteria:
  • Be 18 years of age or older.
  • Able to provide informed consent.
  • Have a clinical diagnosis of one of the following as confirmed by the NIH movement disorders clinic team and the multi-disciplinary DBS surgical conference, and deemed as appropriate for the use of Deep Brain Stimulation therapy:
  • idiopathic PD not adequately controlled with medication or
  • primary dystonia that is medically refractory, or
  • ET that is not adequately controlled by medications or constitutes a significant functional disability.
  • EXCLUSION CRITERIA:
  • Candidates will be excluded if they:
  • Are unable or unwilling to give informed consent to the research procedures.

About National Institute Of Neurological Disorders And Stroke (Ninds)

The National Institute of Neurological Disorders and Stroke (NINDS) is a leading component of the National Institutes of Health (NIH), dedicated to advancing our understanding of the brain and nervous system through innovative research. NINDS sponsors and conducts clinical trials aimed at developing effective treatments and improving patient outcomes for a wide range of neurological disorders, including stroke, epilepsy, multiple sclerosis, and neurodegenerative diseases. By fostering collaboration among researchers, healthcare providers, and patient communities, NINDS plays a pivotal role in transforming scientific discoveries into clinical applications, ultimately enhancing the quality of life for individuals affected by neurological conditions.

Locations

Bethesda, Maryland, United States

Bethesda, Maryland, United States

Patients applied

0 patients applied

Trial Officials

Kareem A Zaghloul, M.D.

Principal Investigator

National Institute of Neurological Disorders and Stroke (NINDS)

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials